Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduccion de la Mortalidad Mediante Plasma-Adsorción en Shock séptico (ROMPA)

NCT02357433 is registered in ClinicalTrials.gov with Francisco Colomina Climent as lead sponsor.

NCT NCT02357433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02357433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduccion de la Mortalidad Mediante Plasma-Adsorción en Shock séptico (ROMPA)
Lead sponsor
Francisco Colomina Climent
Phase
Not applicable
Overall status
Terminated
Start date
February 28, 2015
Completion date
June 30, 2018
Enrollment
55 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock